Latex protein levels in external condom catheters

Area of Science:

• Biomedical Engineering
• Materials Science
• Analytical Chemistry

Background:

• The U.S. Food and Drug Administration (FDA) permits labeling for medical products with reduced total water-extractable latex protein.
• The American Society for Testing and Materials (ASTM) standard for latex protein analysis is the modified Lowry assay, a colorimetric method.
• Accurate quantification of low latex protein levels is crucial for product safety and efficacy.

Purpose of the Study:

• To evaluate the specificity of the modified Lowry assay for measuring total water-extractable latex proteins.
• To compare protein levels between different brands of external condom catheters.
• To determine the assay's suitability for identifying medical products with extremely low latex protein content.

Main Methods:

• Analysis of latex protein levels in external condom catheters from two different brands.
• Utilized the modified Lowry assay, a standard colorimetric method with a precipitation step.
• Considered immunochemical assays as a more specific alternative for protein quantification.

Main Results:

• A significant difference in protein levels was observed between the two brands of external condom catheters analyzed.
• The modified Lowry assay demonstrated significantly lower specificity compared to immunochemical assays for detecting total water-extractable latex proteins.
• The nonspecificity of the modified Lowry assay poses challenges in accurately quantifying extremely low protein levels.

Conclusions:

• The modified Lowry assay's lack of specificity hinders accurate measurement of low total water-extractable latex protein levels.
• This limitation impacts the reliable identification and labeling of medical products intended to have reduced protein content.
• Further development or adoption of more specific assays, such as immunochemical methods, is recommended for accurate latex protein quantification.